article thumbnail

As Viatris seeks growth in eye care, its Ocuphire-partnered dilation drop Ryzumvi wins FDA nod

Fierce Pharma

The FDA on Wednesday approved Viatris and Ocuphire’s Ryzumvi, also known as phentolamine ophthalmic solution, to treat pharmacologically-induced mydriasis, or dilation of the pupils. Viatris just notched a win on its quest to reach $1 billion in eye care sales by 2028. | The partners plan to make Ryzumvi available in the U.S.

article thumbnail

Mastering the Path to Pharma Sales Success: Your Ultimate Guide

Pharmaceutical Representative Training

Unveiling the Role of a Pharma Sales Rep Pharmaceutical sales representatives (PSRs) play a pivotal role in driving sales for their company’s pharmaceutical products. PSRs must possess a robust understanding of pharmacology, adeptly navigating inquiries on drug mechanisms, side effects, and interactions. Why Choose Pharma Sales?

Sales 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Viatris, Ocuphire Pharma Receive FDA Approval on Ryzumvi

PharmExec

Eye drop treatment indicated for pharmacologically induced mydriasis.

article thumbnail

Top 5 Best Online Pharma Sales Certification Courses

Pharmaceutical Representative Training

Although this is a competitive profession, registering for an online pharma sales training course from a reputable institution can bring you one step closer to attaining your professional goals in this field. Thus, you need a pharma sales certification course to build a career in the pharmaceutical sales industry. Key Takeaway.

article thumbnail

invoX Pharma agrees to acquire biopharma firm F-star Therapeutics for $161m

Pharmaceutical Technology

invoX Pharma has signed a definitive agreement for the acquisition of all issued and outstanding shares of clinical-stage biopharma firm F-star Therapeutics, in a deal valued at nearly $161m or $7.12 invoX Pharma is a fully owned Sino Biopharmaceutical subsidiary. for each share in cash.

article thumbnail

Tackling the complex development landscape of pain medicines

European Pharmaceutical Review

There is a clear trend away from developing pharmacological therapies targeting opioid receptors” There is a clear trend away from developing pharmacological therapies targeting opioid receptors. Towards the end of 2023, one sensed an emerging interest from Big Pharma in neuroscience. References Cruccu G, Truini A.

article thumbnail

Pharmaceutical Sales Training: Mastering the Art of Modern Pharma Sales

Contrarian Sales Techniques

It's the secret sauce to thriving in the pharma industry. From cutting-edge training techniques that break the mold, to the latest industry trends making waves, and the career development hacks every pharma rep should know – we've got it all covered. Welcome to the world where sales training isn't just a formality.